从美国和中国甲状腺功能亢进症诊治指南看妊娠和哺乳期抗甲亢药物的选择

Advance in selection of antithyroid drugs during pregnancy and lactation from American and Chinese hyperthyroidism treatment guidelines

妊娠及哺乳期合并甲状腺功能亢进(甲亢)的合理治疗,是临床面临的共同难题之一,也是引起母婴病死率升高的主要原因之一。随着美国和中国甲亢诊治指南的不断翻新,可以看出治疗妊娠和哺乳期甲亢的药物治疗方案有不少进展,本文将甲亢诊治指南中有关抗甲状腺药物治疗的更新作一总结,以为临床合理用药提供参考。

Management of hyperthyroidism in pregnancy and lactation has been the topic for many years. Uncontrolled hyperthyroidism is associated with the increasing of morbidity and mortality of maternal and infants. Hyperthyroidism management guidelines in American and China were updated, wite many advance in regime of antithyroid drugs. In this article, we compared and summarized the advance of different guidelines to supply reference to the rational drug use.